FISIOLOGÍA Y FARMACOLOGÍA
Departamento
University of Regensburg
Ratisbona, AlemaniaPublicaciones en colaboración con investigadores/as de University of Regensburg (11)
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
International Journal of Molecular Sciences, Vol. 24, Núm. 3
2022
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
-
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
Hepatology, Vol. 73, Núm. 6, pp. 2311-2325
-
REPLY:
Hepatology
-
REPLY:
Hepatology
2020
-
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588
-
Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury
Laboratory Investigation, Vol. 100, Núm. 11, pp. 1455-1464
2019
-
Cholangiocarcinoma: State-of-the-art knowledge and challenges
Liver International
2006
-
TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells
Kidney International, Vol. 70, Núm. 5, pp. 901-909